DeepMed Research

UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.uhhospitals.org

Clinical Trials

Compliance of Compression Therapy in Healed Venous Ulcerations

Not Applicable

Withdrawn

Conditions: Venous Insufficiency

Interventions: Device: Compression stocking 15-20mmHg
Device: Compression stocking 20-30mmHg

First Posted Date: 2012-09-07

Last Posted Date: 2022-05-17

Lead Sponsor: University Hospitals Cleveland Medical Center

Registration Number: NCT01680809

Locations: 🇺🇸
Richmond Medical Center (University Hospitals of Cleveland), Richmond Heights, Ohio, United States

Life 4°C Versus Optisol in Corneal Storage Media

Phase 3

Completed

Conditions: Complications of Corneal Transplant

Interventions: Other: Corneal donor storage in Optisol GS media solution
Other: Life 4°C solution for cornea storage

First Posted Date: 2012-08-06

Last Posted Date: 2022-04-18

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 64

Registration Number: NCT01657500

Locations: 🇺🇸
Verdier Eye Center, Grand Rapids, Michigan, United States
🇺🇸
Price Vision Group, Indianapolis, Indiana, United States
🇺🇸
Central Pennsylvannia Eye Institute, Hershey, Pennsylvania, United States

and more 1 locations

Electrical and Formocresol Pulpotomy in Primary Molars

Not Applicable

Terminated

Conditions: Caries
Reversible Pulpitis

Interventions: Procedure: Formocresol application after pulpotomy preparation
Procedure: GENTLEray 980 Soft Tissue diode laser

First Posted Date: 2012-06-18

Last Posted Date: 2017-05-10

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 120

Registration Number: NCT01622153

Locations: 🇺🇸
University Hospital-Rainbow Babies & Children's Hospital, Cleveland, Ohio, United States

Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease

Phase 1

Terminated

Conditions: Alzheimer's Disease

Interventions: Drug: Isotretinoin

First Posted Date: 2012-03-22

Last Posted Date: 2022-06-15

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 3

Registration Number: NCT01560585

Locations: 🇺🇸
Parkway Medical Building, Beachwood, Ohio, United States

Gao Bipolar Spectrum Lithium/Quetiapine Study

Phase 4

Terminated

Conditions: Bipolar Disorder

Interventions: Drug: Lithium
Drug: Quetiapine

First Posted Date: 2012-02-03

Last Posted Date: 2017-08-16

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 42

Registration Number: NCT01526148

Locations: 🇺🇸
University Hospitals Cleveland Medical Center - Mood Disorders Program, Cleveland, Ohio, United States

Vitamin D Supplementation in HIV Youth

Phase 2

Completed

Conditions: HIV Infections

Interventions: Drug: Vitamin D control dose
Drug: Vitamin D supplementation-

First Posted Date: 2012-02-01

Last Posted Date: 2018-03-08

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 190

Registration Number: NCT01523496

Locations: 🇺🇸
University Hospitals Case Medical Center, Cleveland, Ohio, United States
🇺🇸
Emory Children's Center, Atlanta, Georgia, United States

Intrapartum Epidural Fentanyl and Breastfeeding in the Immediate Postpartum Period: a Randomized, Controlled, Double-blinded Study

Not Applicable

Withdrawn

Conditions: Neonatal Neurobehavior
Breastfeeding Outcomes

First Posted Date: 2011-12-22

Last Posted Date: 2022-04-18

Lead Sponsor: University Hospitals Cleveland Medical Center

Registration Number: NCT01497509

Locations: 🇺🇸
University Hospitals Case Medical Center, Cleveland, Ohio, United States

Intrapartum Epidural Fentanyl and Breast-feeding in the Immediate Postpartum Period: a Prospective Cohort Study

Withdrawn

Conditions: Breast Feeding
Nalbuphine
Fentanyl
Maternal Anaesthesia and Analgesia Affecting Fetus or Newborn
Bupivacaine

First Posted Date: 2011-12-08

Last Posted Date: 2022-04-18

Lead Sponsor: University Hospitals Cleveland Medical Center

Registration Number: NCT01488149

Locations: 🇺🇸
University Hospital Case Medical Center, Cleveland, Ohio, United States

Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer

Phase 4

Terminated

Conditions: Scar

Interventions: Drug: Dysport (abobotulinumtoxinA)
Drug: Bacteriostatic 0.9% Sodium Chloride (vehicle)

First Posted Date: 2011-10-26

Last Posted Date: 2022-05-26

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 9

Registration Number: NCT01459666

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸
UH Cleveland Medical Center-Westlake, Westlake, Ohio, United States

Asenapine in the Treatment of Older Adults With Bipolar Disorder

Phase 4

Completed

Conditions: Bipolar Disorder

Interventions: Drug: Asenapine

First Posted Date: 2011-10-26

Last Posted Date: 2014-12-30

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 15

Registration Number: NCT01460290

Locations: 🇺🇸
University Hospitals Case Medical Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy